HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of acute and cutaneous porphyrias.

Abstract
The porphyrias comprise a group of disorders of the haem biosynthesis pathway that can present with acute neurovisceral symptoms, skin lesions or both. Acute porphyrias present with severe abdominal pain, confusion and seizures which may be life-threatening. Specific treatment with haem preparations should be instituted as soon as possible following confirmation of increased excretion of porphobilinogen in the urine. Supportive treatment includes opiate analgesia, monitoring for and treating complications such as hypertension and hyponatraemia. Follow-up should include counselling on lifestyle modification involving avoidance of alcohol, smoking and known porphyrogenic drugs and diet. Identification and counselling of at risk relatives is essential. The cutaneous porphyrias result from porphyrin-induced photosensitivity and can present with either acute photosensitivity or skin fragility and blisters. All cutaneous porphyrias can be alleviated by avoidance of sunlight. Treatment of erythropoietic protoporphyria involves administering large doses of beta-carotene, which may improve tolerance to sunlight. Porphyria cutanea tarda can be effectively treated by phlebotomy or low dose chloroquine. Congenital erythropoietic porphyria is a rare, early onset, severe, photomutilating condition for which bone marrow transplantation has been shown to be successful.
AuthorsM N Badminton, G H Elder
JournalInternational journal of clinical practice (Int J Clin Pract) Vol. 56 Issue 4 Pg. 272-8 (May 2002) ISSN: 1368-5031 [Print] India
PMID12074210 (Publication Type: Journal Article, Review)
Chemical References
  • Estrogens
  • beta Carotene
  • Ethanol
  • Heme
  • Chloroquine
  • Arginine
  • heme arginate
Topics
  • Arginine (therapeutic use)
  • Chloroquine (therapeutic use)
  • Estrogens (adverse effects)
  • Ethanol (adverse effects)
  • Heme (therapeutic use)
  • Humans
  • Phlebotomy
  • Porphyria Cutanea Tarda (etiology, therapy)
  • Porphyria, Acute Intermittent (etiology, therapy)
  • Porphyrias (etiology, therapy)
  • Sunlight (adverse effects)
  • beta Carotene (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: